ING-DiBa AG:企業の戦略的SWOT分析

◆英語タイトル:ING-DiBa AG - Strategic SWOT Analysis Review
◆商品コード:DATA904C13729
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ING-DiBa AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

ING-DiBa AG (ING-DiBa), a subsidiary of ING Deutschland GmbH, is a provider of banking, securities, and other financial solutions. The bank’s portfolio of products include savings deposits, current accounts, mortgage loans, consumer and corporate loans, structured finance, real estate finance, and retirement products. ING-DiBa provides various services such as asset management, transaction services, and global capital market services. It also provides construction financing services that include personal advice, new financing, follow-up financing, forward loans, and KfW programs. The bank has operations in Austria and Germany. ING-DiBa is headquartered in Frankfurt am Main, Hessen, Germany.

ING-DiBa AG Key Recent Developments

Feb 06,2018: BW LPG Signs USD150 Million Senior Secured Term Loan Agreement

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
ING-DiBa AG – Key Facts
ING-DiBa AG – Key Employees
ING-DiBa AG – Major Products and Services
ING-DiBa AG – History
ING-DiBa AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ING-DiBa AG – Business Description
Business Segment: Retail Customer Assets
Overview
Performance
Key Stats
Business Segment: Retail Customer Loans
Overview
Performance
Key Stats
Business Segment: Wholesale Banking
Overview
Performance
Key Stats
ING-DiBa AG – SWOT Analysis
SWOT Analysis – Overview
ING-DiBa AG – Strengths
ING-DiBa AG – Weaknesses
ING-DiBa AG – Opportunities
ING-DiBa AG – Threats
ING-DiBa AG – Key Competitors
Section 3 – Company’s Recent Developments
Feb 06, 2018: BW LPG Signs USD150 Million Senior Secured Term Loan Agreement
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
ING-DiBa AG, Key Facts
ING-DiBa AG, Key Employees
ING-DiBa AG, Major Products and Services
ING-DiBa AG, History
ING-DiBa AG, Subsidiaries
ING-DiBa AG, Key Competitors

★海外企業調査レポート[ING-DiBa AG:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Integer Holdings Corp (ITGR)-医療機器分野:企業M&A・提携分析
    Summary Integer Holdings Corp (Integrated Holdings), formerly Greatbatch Inc is a medical device outsource manufacturer that designs and develops medical devices and power solutions for the medical and non-medical markets. The company offers products such as arthroscopic devices and components, lapa …
  • Acerinox Group:企業の戦略・SWOT・財務情報
    Acerinox Group - Strategy, SWOT and Corporate Finance Report Summary Acerinox Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • AngloGold Ashanti Ltd:企業のM&A・事業提携・投資動向
    AngloGold Ashanti Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AngloGold Ashanti Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Innate Pharma SA (IPH)-製薬・医療分野:企業M&A・提携分析
    Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclo …
  • Connecticut Municipal Electric Energy Cooperative:企業の戦略的SWOT分析
    Connecticut Municipal Electric Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Biomerica Inc (BMRA):企業の製品パイプライン分析
    Summary Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose v …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • Caledonia Investments plc:企業の戦略・SWOT・財務情報
    Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report Summary Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Petrochemical Corporation of Singapore (Private) Ltd:企業の戦略的SWOT分析
    Petrochemical Corporation of Singapore (Private) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key comp …
  • American Superconductor Corp (AMSC):企業の財務・戦略的SWOT分析
    American Superconductor Corp (AMSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PCI Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary PCI Pharma Services (PCI) is a drug development company that offers clinical manufacturing and packaging solutions. The company offers clinical services such as pharmaceutical development, clinical trial manufacturing, clinical trial packaging, clinical supplies management, clinical planning …
  • Facebook Inc (FB):企業の財務・戦略的SWOT分析
    Facebook Inc (FB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Snap-on Incorporated (SNA):企業の財務・戦略的SWOT分析
    Snap-on Incorporated (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Adamis Pharmaceuticals Corp (ADMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Roche Diagnostics International Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in vitro diagnos …
  • HedgePath Pharmaceuticals Inc (HPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Hedgepath Pharmaceuticals Inc (Hedgepath), a subsidiary of Mayne Pharma Group Ltd, is a clinical stage biopharmaceutical company that discovers, develops and commercializes novel therapeutics for the treatment of skin, prostrate, and lung cancers. The company is investigating an oral formula …
  • Toyobo Co Ltd (3101):企業の財務・戦略的SWOT分析
    Toyobo Co Ltd (3101) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆